Suppr超能文献

内脏淤血和肠道微环境在心力衰竭进展中的作用。

The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.

机构信息

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

Curr Opin Support Palliat Care. 2019 Mar;13(1):24-30. doi: 10.1097/SPC.0000000000000414.

Abstract

PURPOSE OF REVIEW

Right-sided heart failure, which is often present in the setting of advanced heart failure, is associated with cardiac cachexia, the cardiorenal syndrome, and adverse outcomes. Improved understanding of venous congestion of the splanchnic circulation, which may play a key role in the pathogenesis of right-sided heart failure, could lead to novel therapeutics to ameliorate heart failure. Here we provide an overview of right-sided heart failure, splanchnic hemodynamics, fluid homeostasis, and the intestinal microenvironment. We review recent literature to describe pathophysiologic mechanisms and possible therapeutics.

RECENT FINDINGS

Several possible mechanisms centered around upregulation of sodium-hydrogen exchanger-3 (NHE3) may form a causal link between right ventricular dysfunction, splanchnic congestion, and worsening heart failure. These include an anaerobic environment in enterocytes, resulting in reduced intracellular pH; increased sodium absorption by the gut via NHE3; decreased pH at the intestinal brush border thus altering the gut microbiome profile; increased bacterial synthesis of trimethylamine N-oxide; and decreased bacterial synthesis of short-chain fatty acids causing abnormal intestinal barrier function.

SUMMARY

Splanchnic congestion in the setting of right-sided heart failure may serve an important role in the pathogenesis of advanced heart failure, and further exploration of these mechanisms may lead to new therapeutic advances.

摘要

目的综述

右心衰竭常发生于晚期心力衰竭患者,与心脏恶病质、心肾综合征和不良预后相关。对内脏循环静脉淤血(可能在右心衰竭发病机制中起关键作用)的理解的提高,可能会带来改善心力衰竭的新疗法。本文概述了右心衰竭、内脏血流动力学、液体平衡和肠道微环境,并复习了相关文献,以描述病理生理机制和可能的治疗方法。

最近的发现

几种可能的机制集中在钠氢交换体 3(NHE3)的上调上,可能在右心室功能障碍、内脏淤血和心力衰竭恶化之间形成因果关系。这些机制包括肠细胞中的厌氧环境导致细胞内 pH 值降低;肠道通过 NHE3 吸收更多的钠;肠道刷状缘的 pH 值降低,从而改变肠道微生物组谱;细菌合成三甲胺 N-氧化物增加;以及短链脂肪酸合成减少导致肠道屏障功能异常。

总结

右心衰竭时的内脏淤血可能在晚期心力衰竭的发病机制中起重要作用,对这些机制的进一步探索可能会带来新的治疗进展。

相似文献

3
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.充血性心力衰竭中心肾功能障碍的腹部贡献。
J Am Coll Cardiol. 2013 Aug 6;62(6):485-95. doi: 10.1016/j.jacc.2013.04.070. Epub 2013 Jun 7.
5
Right Heart Failure and Cardiorenal Syndrome.右心衰竭与心肾综合征。
Cardiol Clin. 2020 May;38(2):185-202. doi: 10.1016/j.ccl.2020.01.004. Epub 2020 Mar 2.
6
7
Exploring the Microbiome in Heart Failure.探索心力衰竭中的微生物群。
Curr Heart Fail Rep. 2016 Apr;13(2):103-9. doi: 10.1007/s11897-016-0285-9.
8
Impact of intestinal microbiota in patients with heart failure: A systematic review.心力衰竭患者肠道微生物群的影响:系统评价。
Med Clin (Barc). 2019 Nov 29;153(10):402-409. doi: 10.1016/j.medcli.2019.06.006. Epub 2019 Aug 12.
9
Heart Failure: a Punch from the Gut.心力衰竭:来自腹部的打击。
Curr Heart Fail Rep. 2024 Apr;21(2):73-80. doi: 10.1007/s11897-024-00648-y. Epub 2024 Feb 1.

引用本文的文献

7
Thrombosis and Thrombotic Risk in Athletes.运动员的血栓形成与血栓形成风险
J Clin Med. 2024 Aug 19;13(16):4881. doi: 10.3390/jcm13164881.

本文引用的文献

2
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
4
Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.微生物短链脂肪酸与血压调节
Curr Hypertens Rep. 2017 Apr;19(4):25. doi: 10.1007/s11906-017-0722-5.
8
Oxygen metabolism and barrier regulation in the intestinal mucosa.肠道黏膜中的氧代谢与屏障调节
J Clin Invest. 2016 Oct 3;126(10):3680-3688. doi: 10.1172/JCI84429. Epub 2016 Aug 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验